(Q31884454)

4 July 2017

1 reference

title

Clinical significance of determination of surrogate markers of angiogenesis in breast cancer (English)

1 reference

4 July 2017

1 reference

Gasparini G

1

1 reference

4 July 2017

1 February 2001

1 reference

Critical Reviews in Oncology Hematology

4 July 2017

1 reference

4 July 2017

37

1 reference

4 July 2017

97-114

1 reference

4 July 2017

2

1 reference

Integrins: versatility, modulation, and signaling in cell adhesion

4 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Interactions of cancer cells with the microvasculature during metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

1 reference

7 January 2021

The structural and mechanical complexity of cell-growth control

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Isolation of putative progenitor endothelial cells for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Cellular and molecular mechanisms of endothelial cell dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Endothelial cell activation. A central pathophysiological process

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Clinical applications of angiogenic growth factors and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Angiogenesis inhibitors generated by tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Antiangiogenis restricted tumor dormancy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Oncogenes as inducers of tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Regulation of integrin function by the urokinase receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Cell adhesion and angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Perspectives series: cell adhesion in vascular biology. Integrin signaling in vascular biology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Functions of the von Hippel-Lindau tumour suppressor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Endothelial apoptosis in Braf-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The implications of angiogenesis for the biology and therapy of cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The rationale and future potential of angiogenesis inhibitors in neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Determination of epidermal growth factor receptor provides additional prognostic information to measuring tumor angiogenesis in breast carcinoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Microvessel quantitation and prognosis in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Is the relationship between angiogenesis and metastasis in breast cancer real?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Prognostic significance of microvessel density in lymph node negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma: a comparison of computer-assisted image analysis with established counting methods.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Independent Prognostic Factors in Breast Cancer Patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Vascular enumeration as a significant prognosticator for invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The methodology of quantitation of microvessel density and prognostic value of neovascularization associated with long-term survival in Japanese patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Macromolecular interstitial clearance, tumour vascularity, other prognostic factors and breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor microvessel density and prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor angiogenesis in node-negative breast carcinomas ? relationship with epidermal growth factor receptor, estrogen receptor, and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Assessment of angiogenesis in breast carcinoma: an important factor in prognosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor induction of VEGF promoter activity in stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Molecular and biological properties of the vascular endothelial growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Reciprocal relation between VEGF and NO in the regulation of endothelial integrity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Soluble VEGF receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Thymidine phosphorylase is angiogenic and promotes tumor growth.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Angiogenic activity of enzymes.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

What is the role of thymidine phosphorylase in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The ins and outs of fibroblast growth factors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The role of angiogenic growth factors in breast cancer progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

FGF-1 but not FGF-4 secreted by carcinoma cells promotes in vitro and in vivo angiogenesis and rapid tumor proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Structural basis for FGF receptor dimerization and activation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Quantitative analysis of vascular endothelial growth factor in primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Distinct angiogenic patterns are associated with high-grade in situ ductal carcinomas of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Upregulation of basic fibroblast growth factor in breast carcinoma and its relationship to vascular density, oestrogen receptor, epidermal growth factor receptor and survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Thrombocytes are the major source for soluble vascular endothelial growth factor in peripheral blood

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Blood platelets and serum VEGF in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Serum basic fibroblast growth factor and vascular endothelial growth factor in metastatic renal cell carcinoma treated with interferon alfa-2b

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Antiangiogenic drugs as a novel anticancer therapeutic strategy. Which are the more promising agents? What are the clinical developments and indications?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

Automated quantification of color Doppler signals: a preliminary study in breast tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2800%2900105-0

7 January 2021

10.1016/S1040-8428(00)00105-0

Identifiers

DOI

1 reference

4 July 2017

1 reference

PubMed ID

11166583